Cortigent, Inc. (CRGT)
Cortigent will go public soon, but the exact IPO date is still unknown.
IPO Price
$10.00
Shares Offered
1,500,000
Deal Size
$15.00M
Cortigent Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
65.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCRGT News
- 1 year ago - IPO Update: Cortigent Readies $15 Million Mini-IPO - Seeking Alpha
- 1 year ago - U.S. IPO Weekly Recap: Small Deals Slip Through The IPO Window - Seeking Alpha
- 1 year ago - Cortigent Seeks $17 Million U.S. IPO For Orion Neurostimulation Device Development - Seeking Alpha
- 1 year ago - Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division - Business Wire
- 1 year ago - Visual prosthetics developer Cortigent files for a $17 million IPO - Renaissance Capital
- 1 year ago - Cortigent IPO Registration Document (S-1) - SEC